It's Boston local news in one concise, fun and informative emailThank you! You have been subscribed to WBUR Today.We were unable to subscribe you to WBUR Today. You can try subscribing here or try again later.
This Food and Drug Administration approved Luxturna, a gene therapy developed by Spark Therapeutics, to treat an inherited form of blindness. (Courtesy of Spark Therapeutics via AP)
